First Quarter 2025 Financial Results May 9, 2025 CAUTIONARY STATEMENTS Forward-Looking Statements This Presentation has been prepared by Calumet, Inc. (the "Company," "Calumet," "we," "our" or like terms) as of May 9, 2025. The information in this Presentation includes certain "forward- looking statements." These statements can be identified by the use of forward-looking terminology including "may," "intend," "believe," "expect," "anticipate," "estimate," "forecast," "outlook," "continue" or other similar w ...

Financial Data and Key Metrics Changes - Revenues for the year ended December 31, 2024, were $268 million, up from $187 million in 2023, with all three segments reporting increases [7] - Cost of goods sold increased from $184.7 million in 2023 to $268.2 million in 2024, aligning with revenue changes [8] - Net loss was $87.5 million for 2024, compared to a net loss of $46.4 million in 2023 [10] Business Line Data and Key Metrics Changes - California ethanol revenue increased by $57.7 million, India biodiesel revenue increased by $15.7 million, and California renewable natural gas revenue increased by $7.6 million [8] - The dairy renewable natural gas segment accounted for $5.4 million of gross profit, primarily from the sale of environmental attributes [9] Market Data and Key Metrics Changes - The price of California LCFS credits increased from $44 to $75 by February 2025, but a recent delay in implementation caused a 30% decrease in prices [15][16] - The expected increase in LCFS credit prices could reach $200 per ton, significantly benefiting Aemetis' biogas and ethanol businesses [17] Company Strategy and Development Direction - Aemetis aims to benefit from supportive public policies for domestic energy producers, focusing on biogas, ethanol, and biodiesel growth [12] - The company is preparing for an IPO of its India biodiesel business, expected in late 2025 or early 2026, contingent on new OMC orders [29] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the REAP program and expects approvals for new funding soon [45][46] - The company anticipates that the approval of E15 blends will significantly expand the U.S. ethanol market by up to 50% [22][24] Other Important Information - Capital expenditures for carbon intensity reduction projects were $20.3 million in 2024, with ongoing projects aimed at increasing production capacity [10] - Aemetis has received conditional commitments for $75 million in USDA guaranteed loans for biogas digester construction [31] Q&A Session Summary Question: Confidence levels around refinancing given government spending reductions - Management has high confidence in the REAP program and expects approvals soon [45][46] Question: Insight into the OAL's request for revisions and expected delays - The complexity of the LCFS legislation led to the OAL's request for clarifications, causing a potential 120-day delay [57][58] Question: Status of India biodiesel production and OMC tender process - A new tender is expected to be issued soon, with significant inventory available for initial shipments [64][65] Question: Expected spending plans for 2025 amid regulatory turbulence - Aemetis plans a $75 million capital budget supported by USDA loans and grants, with an acceleration in biogas investments [78][79] Question: Impact of E15 approvals on ethanol margins - E15 adoption is expected to be gradual, with significant margin improvements anticipated by 2027 [84][90] Question: Timing of CARB policy implementation - Management estimates a 2-3 month timeline for CARB policy implementation, with no definitive endpoint [92] Question: Drivers of negative EBITDA results in Q4 - Oversupply and high corn prices were significant factors, but operational adjustments are expected to improve Q1 performance [98][100] Question: Expectations on D3 RVO going forward - The EPA's recent actions suggest a lower D3 RIN mandate for 2024, impacting future investment growth [106][112]